We are live on
!
Find out more
VCM
Versant Capital Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
34.21%
This Fund
S&P 500
This Quarter
Est. Return
+13.52%
1 Year Est. Return
+34.21%
3 Year Est. Return
+82.39%
5 Year Est. Return
+89.4%
10 Year Est. Return
+245.39%
AUM
$1.12B
AUM Growth
+$101M
(+10%)
Cap. Flow
+$19.1M
Cap. Flow
% of AUM
1.71%
Top 10 Holdings %
Top 10 Hldgs %
31.56%
Holding
2,873
New
96
Increased
1,181
Reduced
859
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXUV
Dimensional US Vector Equity ETF
DXUV
|
+$8.37M |
| 2 |
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
|
+$7.66M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$6.75M |
| 4 |
DXIV
Dimensional International Vector Equity ETF
DXIV
|
+$4.35M |
| 5 |
Dimensional Emerging Markets Value ETF
DFEV
|
+$2.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$2.11M |
| 2 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$2.02M |
| 3 |
Vanguard Total Stock Market ETF
VTI
|
+$1.88M |
| 4 |
CoreCivic
CXW
|
+$1.84M |
| 5 |
Apple
AAPL
|
+$1.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.06% |
| 2 | Financials | 7.05% |
| 3 | Industrials | 6.04% |
| 4 | Consumer Discretionary | 4.74% |
| 5 | Healthcare | 4.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DFSV
2301
Dimensional US Small Cap Value ETF
DFSV
$8.17B
| $7.95K | ﹤0.01% |
205
| – | – |
|
|
HDV
2302
iShares Core High Dividend ETF
HDV
$14.4B
| $7.95K | ﹤0.01% |
290
| – | – |
|
2303
ARS Pharmaceuticals
SPRY
$593M
| $7.94K | ﹤0.01% |
991
-547
| -36% | -$4.71K |
|
|
ITIC
2304
Investors Title Co
ITIC
$538M
| $7.94K | ﹤0.01% |
29
-10
| -26% | -$2.42K |
|
2305
DMC Global
BOOM
$122M
| $7.93K | ﹤0.01% |
1,365
| – | – |
|
2306
Warby Parker
WRBY
$3.1B
| $7.92K | ﹤0.01% |
261
-250
| -49% | -$6.19K |
|
2307
NRC Health Common Stock
NRC
$486M
| $7.92K | ﹤0.01% |
367
| – | – |
|
2308
Diebold Nixdorf
DBD
$3.05B
| $7.91K | ﹤0.01% |
93
-98
| -51% | -$7.88K |
|
2309
BancFirst
BANF
$3.95B
| $7.89K | ﹤0.01% |
+71
| New | +$7.95K |
|
|
AAMI
2310
Acadian Asset Management
AAMI
$2.88B
| $7.87K | ﹤0.01% |
110
| – | – |
|
2311
Consensus Cloud Solutions
CCSI
$679M
| $7.86K | ﹤0.01% |
206
-65
| -24% | -$1.95K |
|
2312
Vontier
VNT
$4.32B
| $7.86K | ﹤0.01% |
271
-3,408
| -93% | -$109K |
|
2313
Oric Pharmaceuticals
ORIC
$1.24B
| $7.8K | ﹤0.01% |
720
-53
| -7% | -$481 |
|
2314
Tredegar Corp
TG
$266M
| $7.79K | ﹤0.01% |
978
| – | – |
|
2315
Driven Brands
DRVN
$2.28B
| $7.76K | ﹤0.01% |
557
+51
| +10% | +$671 |
|
2316
Talos Energy
TALO
$2.5B
| $7.76K | ﹤0.01% |
601
| – | – |
|
2317
Redwire
RDW
$2.12B
| $7.75K | ﹤0.01% |
634
| – | – |
|
2318
UL Solutions
ULS
$17.6B
| $7.74K | ﹤0.01% |
76
+68
| +850% | +$6.43K |
|
2319
Arvinas
ARVN
$523M
| $7.69K | ﹤0.01% |
925
+274
| +42% | +$2.56K |
|
|
QXO
2320
QXO Inc
QXO
$14.3B
| $7.67K | ﹤0.01% |
444
+8
| +2% | +$149 |
|
2321
Thor Industries
THO
$4.02B
| $7.67K | ﹤0.01% |
102
-147
| -59% | -$11.3K |
|
2322
SandRidge Energy
SD
$516M
| $7.66K | ﹤0.01% |
559
| – | – |
|
2323
YieldMax MSTR Option Income Strategy ETF
MSTY
$718M
| $7.64K | ﹤0.01% |
625
+5
| +0.8% | +$107 |
|
|
PSKY
2324
Paramount Skydance Corp
PSKY
$9.49B
| $7.58K | ﹤0.01% |
769
-11
| -1% | -$116 |
|
2325
Appian
APPN
$1.7B
| $7.58K | ﹤0.01% |
331
+9
| +3% | +$200 |
|
Similar funds
FLAM
AIM
MTCM
CNC
NOSC
RIM
ACG
C
Versant Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Versant Capital Management held 2,873 positions worth $1.12B, up 10% from $1.01B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Versant Capital Management's Q2 2026 filing shows 96 new, 1,181 increased, 859 reduced and 128 closed positions. Its largest new stake was AstraZeneca: 7,263 shares worth $1.36M. The largest sale was iShares 3-7 Year Treasury Bond ETF, an estimated $2.11M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Industrials.
- Versant Capital Management's largest Q2 2026 buy was AstraZeneca: 7,263 shares worth $1.36M.
- Versant Capital Management added most to Dimensional US Vector Equity ETF in Q2 2026, an estimated $8.37M increase.
- Versant Capital Management's biggest Q2 2026 reduction was iShares 3-7 Year Treasury Bond ETF, cutting an estimated $2.11M.
- Versant Capital Management fully exited iShares 5-10 Year Investment Grade Corporate Bond ETF in Q2 2026, selling an estimated $2.02M.
- Versant Capital Management's ten largest holdings make up 32% of its $1.12B portfolio in Q2 2026.
- Versant Capital Management opened 96 new positions and closed 128 in Q2 2026.
- Versant Capital Management's portfolio value rose 10% quarter-over-quarter to $1.12B.
Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.